Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 391.38 M393.05 M383 M381.37 M459.68 M 1.62 B Research & development ————— — Operating income 200.94 M423.84 M749.45 M186.64 M232.94 M 1.59 B Non-Operating Income, Total -242.38 M-393.21 M-315.81 M-180.75 M-125.28 M -1.02 B Interest expense, net of interest capitalized 14.72 M10.91 M9.04 M74.54 M5.75 M 100.24 M Non-Operating Income, excl. Interest Expenses -217.87 M-236.78 M-328.82 M-170.04 M-165.99 M -901.62 M Unusual income/expense -24.5 M-156.43 M13 M-10.71 M40.7 M -113.43 M Pretax income -41.44 M30.63 M433.64 M5.89 M107.66 M 577.82 M Equity in earnings ————— — Taxes -1.14 M637 K14.34 M-8.36 M2.99 M 9.61 M Non-controlling/minority interest ————— — After tax other income/expense ————-1.81 M — Net income before discontinued operations -40.3 M29.99 M419.3 M14.25 M104.67 M 568.21 M Discontinued operations ————— — Net income -40.3 M29.99 M419.3 M14.25 M104.67 M 568.21 M Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders -40.3 M29.99 M426.58 M-3.88 M105.44 M 558.13 M Basic earnings per share (Basic EPS) -0.090.070.930.030.23 1.26 Diluted earnings per share (Diluted EPS) -0.090.070.860.080.23 1.24 Average basic shares outstanding 441.15 M446.59 M451 M448.54 M456.65 M — Diluted shares outstanding 441.15 M448.03 M495.73 M477.74 M466.15 M — EBITDA 451.48 M688.27 M1.02 B560.99 M514.33 M 2.79 B EBIT 200.94 M423.84 M749.45 M186.64 M232.94 M 1.59 B Cost of revenue 1.3 B1.46 B1.55 B1.32 B1.38 B 5.71 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 250.53 M264.44 M272.79 M374.35 M281.39 M 1.19 B